About 4-[[(2R)-1-[(1S)-1-(1-cyclopropyltetrazol-5-yl)ethyl]piperidin-2-yl]methyl]morpholine
4-[[(2R)-1-[(1S)-1-(1-cyclopropyltetrazol-5-yl)ethyl]piperidin-2-yl]methyl]morpholine (PubChem CID 124623713) has the molecular formula C16H28N6O
and a molecular weight of 320.44 g/mol. Its IUPAC name is 4-[[(2R)-1-[(1S)-1-(1-cyclopropyltetrazol-5-yl)ethyl]piperidin-2-yl]methyl]morpholine.
Molecular Properties
| Compound Name | 4-[[(2R)-1-[(1S)-1-(1-cyclopropyltetrazol-5-yl)ethyl]piperidin-2-yl]methyl]morpholine |
| PubChem CID | 124623713 |
| Molecular Formula | C16H28N6O |
| Molecular Weight | 320.44 g/mol |
| Exact Mass | 320.23 |
| IUPAC Name | 4-[[(2R)-1-[(1S)-1-(1-cyclopropyltetrazol-5-yl)ethyl]piperidin-2-yl]methyl]morpholine |
| SMILES | C[C@@H](c1nnnn1C1CC1)N1CCCC[C@@H]1CN1CCOCC1 |
| InChI | InChI=1S/C16H28N6O/c1-13(16-17-18-19-22(16)14-5-6-14)21-7-3-2-4-15(21)12-20-8-10-23-11-9-20/h13-15H,2-12H2,1H3/t13-,15+/m0/s1 |
| InChIKey | GYZFSGQGVSNEGV-DZGCQCFKSA-N |
| XLogP | 1.26 |
| TPSA | 59.31 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 320.44 |
| LogP ≤ 5 | 1.26 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 7 |
Analyze 4-[[(2R)-1-[(1S)-1-(1-cyclopropyltetrazol-5-yl)ethyl]piperidin-2-yl]methyl]morpholine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 4-[[(2R)-1-[(1S)-1-(1-cyclopropyltetrazol-5-yl)ethyl]piperidin-2-yl]methyl]morpholine?
The IUPAC name of 4-[[(2R)-1-[(1S)-1-(1-cyclopropyltetrazol-5-yl)ethyl]piperidin-2-yl]methyl]morpholine (CID 124623713) is 4-[[(2R)-1-[(1S)-1-(1-cyclopropyltetrazol-5-yl)ethyl]piperidin-2-yl]methyl]morpholine.
What is the SMILES notation for 4-[[(2R)-1-[(1S)-1-(1-cyclopropyltetrazol-5-yl)ethyl]piperidin-2-yl]methyl]morpholine?
The canonical SMILES for 4-[[(2R)-1-[(1S)-1-(1-cyclopropyltetrazol-5-yl)ethyl]piperidin-2-yl]methyl]morpholine is C[C@@H](c1nnnn1C1CC1)N1CCCC[C@@H]1CN1CCOCC1.
What is the InChIKey of 4-[[(2R)-1-[(1S)-1-(1-cyclopropyltetrazol-5-yl)ethyl]piperidin-2-yl]methyl]morpholine?
The InChIKey is GYZFSGQGVSNEGV-DZGCQCFKSA-N. The full InChI is InChI=1S/C16H28N6O/c1-13(16-17-18-19-22(16)14-5-6-14)21-7-3-2-4-15(21)12-20-8-10-23-11-9-20/h13-15H,2-12H2,1H3/t13-,15+/m0/s1.
What are the key properties of 4-[[(2R)-1-[(1S)-1-(1-cyclopropyltetrazol-5-yl)ethyl]piperidin-2-yl]methyl]morpholine?
4-[[(2R)-1-[(1S)-1-(1-cyclopropyltetrazol-5-yl)ethyl]piperidin-2-yl]methyl]morpholine has a molecular weight of 320.44 g/mol, XLogP of 1.26, 5 rotatable bonds, 0 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[(2R)-1-[(1S)-1-(1-cyclopropyltetrazol-5-yl)ethyl]piperidin-2-yl]methyl]morpholine is sourced from PubChem (CID 124623713), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).